Patritumab deruxtecan
Product Specifications
CAS Number
2227102-46-5
Target
Antibody-Drug Conjugates (ADCs)
Related Pathways
Antibody-drug Conjugate/ADC Related
Purity
>95.0%
Bioactivity
Patritumab deruxtecan (HER3-DXd) is an antibody-drug coupling (ADC) targeting HER3 consisting of a fully humanized anti-HER3 IgG1 monoclonal antibody linked via a cleavable tetrapeptide linker to a topoisomerase I inhibitor payload (an ezetiocan derivative, DXd) for the study of non-small cell lung cancer (NSCLC) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15237784 1 Vial
Lentiviral mouse Ptgdr shRNA (UAS) - Lentiviral mouse Ptgdr shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details ![Mouse Monoclonal CD59 Antibody (MEM-43) [PE/Cy5.5]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NB500-330PECY55 0.1 mL
Mouse Monoclonal CD59 Antibody (MEM-43) [PE/Cy5.5]
Sign In for Pricing
View Details KBH22166 1x 96 Well
GENLISA™ Human Proteasome Subunit Alpha Type 7 (PSMa7) ELISA
Sign In for Pricing
View Details MBS1086636 Inquire
Recombinant Syntrophobacter fumaroxidans Ribonuclease Y (rny), partial
Sign In for Pricing
View Details